Skip to content

Visual Stimulation for Pain Relief

Pain Relief Through Artificial Intelligence (AI) -Guided Dynamic Neuromodulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06276881
Enrollment
75
Registered
2024-02-26
Start date
2022-06-03
Completion date
2023-05-01
Last updated
2024-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

The goal of this study is to investigate a novel neuromodulatory approach utilizing visual stimulation to impact pain perception in healthy participants.

Interventions

AI-guided visual stimuli presented on an electronic screen

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Dandelion Science
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants of both sexes * Participants of diverse ethnic and racial backgrounds * Participants who speak, read, and understand English and are willing and able to provide written informed * 18 to 50 years old

Exclusion criteria

* Participants with neurologic, endocrine, renal, gastrointestinal, and chronic pain disease * Participants who use unprescribed drugs or medications * Chronically medicated participants * Participants with photosensitivity and epileptic seizures * Participants who have undergone major surgery within two months of the experiment date * Participants with cardiac disorders * Participants who are pregnant * Prisoners * Participants who are unable to provide consent * Participants diagnosed with a psychiatric disorder that is likely to interfere with the conduct of the study * Participants with implanted electronic devices of any kind, including pace-makers, electronic infusion pumps, stimulators, defibrillators

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS) ScoreUp to 2 hoursStandard computerized scale of perceived pain level. The scale ranges from 0 to 100, a score of 0 indicating No Pain and a score of 100 indicating Most Pain. Higher score indicates a worse outcome as perceived pain is increasing, lower score indicates a better outcome as perceived pain is decreasing.
Event-related Potential (ERP)Up to 2 hoursEvoked event-related neural response to contact heat perception measured by EEG (electroencephalography), P300 component

Countries

United States

Participant flow

Participants by arm

ArmCount
Healthy Controls
Visual Stimulation: AI-guided visual stimuli presented on an electronic screen
75
Total75

Baseline characteristics

CharacteristicHealthy Controls
Age, Continuous24.97 years
STANDARD_DEVIATION 5.83
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
75 Participants
Sex: Female, Male
Female
41 Participants
Sex: Female, Male
Male
34 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 75
other
Total, other adverse events
0 / 75
serious
Total, serious adverse events
0 / 75

Outcome results

Primary

Event-related Potential (ERP)

Evoked event-related neural response to contact heat perception measured by EEG (electroencephalography), P300 component

Time frame: Up to 2 hours

Population: Sixteen participants' data removed due to noisy data

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Healthy ControlsEvent-related Potential (ERP)31 Participants
p-value: 0.07ANOVA
Primary

Visual Analog Scale (VAS) Score

Standard computerized scale of perceived pain level. The scale ranges from 0 to 100, a score of 0 indicating No Pain and a score of 100 indicating Most Pain. Higher score indicates a worse outcome as perceived pain is increasing, lower score indicates a better outcome as perceived pain is decreasing.

Time frame: Up to 2 hours

Population: Sixteen participants removed from analysis due to noisy data

ArmMeasureGroupValue (MEAN)Dispersion
Healthy ControlsVisual Analog Scale (VAS) ScoreVAS Score in Response to No Visual Stimulation24.77 score on a scaleStandard Deviation 20.51
Healthy ControlsVisual Analog Scale (VAS) ScoreVAS Score in Response to Flicker Visual Stimulation25.02 score on a scaleStandard Deviation 21.55
Healthy ControlsVisual Analog Scale (VAS) ScoreVAS Score in Response to Abstract Visual Stimulation25.19 score on a scaleStandard Deviation 21.13
Healthy ControlsVisual Analog Scale (VAS) ScoreVAS Score in Response to Semantic Visual Stimulation23.64 score on a scaleStandard Deviation 21.19
p-value: 0.37t-test, 1 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026